GDC-0980, a dual PI3K/mTOR inhibitor, selectively inhibits NF2 mutant malignant mesothelioma (MM) cells and inhibits TOR signaling without activating Akt or ERK Meeting Abstract

  

Authors:	Zauderer, M. G.; Moulik, K.; Cooper, J.; Krug, L. M.; Giancotti, F.
Abstract Title:	GDC-0980, a dual PI3K/mTOR inhibitor, selectively inhibits NF2 mutant malignant mesothelioma (MM) cells and inhibits TOR signaling without activating Akt or ERK
Meeting Title:	AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer
Journal Title:	Molecular Cancer Therapeutics
Volume:	14
Issue:	7 Suppl.
Meeting Dates:	2014 Sep 14-17
Meeting Location:	Philadelphia, PA
ISSN:	1535-7163
Publisher:	American Association for Cancer Research
Date Published:	2015-07-01
Language:	English
ACCESSION:	WOS:000358159200029
DOI:	10.1158/1538-8514.pi3k14-a34
PROVIDER:	wos
Notes:	Meeting Abstract A34 -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/77350